Answers are grounded in this paper and cite their sources.
Two companies, MRL and Meridian Diagnostics, have developed Food and Drug Administration-approved herpes simplex virus type 1 type-specific enzyme immunoassays. The sensitivity, specificity, and overall testing efficiency of these assays were 98.2, 93.8, and 96.6% for MRL and 98.8, 99.0, and 98.1% for Meridian, making both of these kits suitable for use in the clinical lab.
No takes yet. Share an insight, caveat, or question.
Ribes et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: